NT-Z001

N/A

Report date: 2024/03/12 17:53:28

Base Information

Drug NameNT-Z001
Drug Alias NameNT-Z001
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionSodium channel protein type IX alpha subunit modulators
TargetsSodium channel protein type IX alpha subunit
Therapy Area/IndicationsChronic Pain
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavega Therapeutics LLC
China Registration ClassN/A

Develop Information

Active CompaniesNavega Therapeutics IncNavega Therapeutics LLC
Inactive CompaniesN/A
Active IndicationsChronic Pain
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A